Therefore, this report, in addition to our earlier studies, provides a promising methodology and validation platform for understanding the possible molecular origins of functional loss of newly identified Angiogenin mutations and their association with ALS pathophysiology. This evidence concerns the gene ANG and amyotrophic lateral sclerosis.